REQUEST A DEMO
Total
USD $0.00
Search more companies

Synlab Czech S.R.O. (Czech Republic)

Main Activities: Outpatient Care Centers | All Other Ambulatory Health Care Services
Secondary Activities: Other Communications Equipment Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Materials Recovery Facilities | Repair and Maintenance
Full name: Synlab Czech S.R.O. Profile Updated: March 02, 2026
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English Download a sample report

Synlab Czech S.R.O. provides laboratory diagnostics, outpatient medical services and sample collection infrastructure in the Czech Republic as part of the multinational SYNLAB Group. Business segments and services include human medical laboratory diagnostics with a broad portfolio of laboratory methods supporting routine and specialized testing, complemented by logistics for sample collection, transport and fast processing, and delivery of results to physicians and patients via digital channels; operation of collection sites and laboratories including statim laboratory capabilities; and operation of specialized outpatient clinics across multiple disciplines, supported by direct-to-public preventive testing offerings via e-commerce ordering of laboratory examinations. Service portfolio spans major diagnostic domains including biochemistry, diabetology, endocrinology, hematology, hormone testing, lipid metabolism and microbiology, complemented by professional support services for partner physicians including consultations with laboratory specialists and operational support services. Geographic scope is nationwide across the Czech Republic supported by an extensive network of collection points, laboratories and outpatient clinics, and is embedded in a global group footprint operating across multiple countries. Key assets include the national laboratory and collection network, multidisciplinary diagnostic know-how, scientific teams supporting development and deployment of new methods, and integrated logistics and digital reporting processes enabling fast turnaround and scalability. Strategic focus and positioning are on high-quality, rapid and comprehensive diagnostic services delivered through an integrated network model, expanding accessibility of preventive testing while maintaining strong professional support for healthcare providers and continuous method innovation.

Headquarters
Sokolovska 100/94
Prague; The City of Prague; Postal Code: 18600

Contact Details: Purchase the Synlab Czech S.R.O. report to view the information.

Website: http://www.klinlab.cz

Basic Information
Total Employees:
Purchase the Synlab Czech S.R.O. report to view the information.
Registered Capital:
Purchase the Synlab Czech S.R.O. report to view the information.
Financial Auditors:
Purchase the Synlab Czech S.R.O. report to view the information.
Incorporation Date:
October 22, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Synlab Cytologie S.R.O.
100%
Synlab Genetics s.r.o.
100%
SYNLAB.CZ s.r.o.
99.9%
Company Performance
Financial values in the chart are available after Synlab Czech S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
13.05%
Total operating revenue
12.85%
Operating Profit/Loss (EBIT)
51.29%
EBITDA
39.64%
Net Profit/Loss for the Period
58.8%
Total Assets
16.99%
Total Equity
23.3%
Operating Profit Margin (ROS)
6.2%
Net Profit Margin
5.67%
Return on Equity (ROE)
11.41%
Quick Ratio
0.92%
Cash Ratio
-0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?